Literature DB >> 12480662

Time between onset of apoptosis and release of nucleosomes from apoptotic cells: putative implications for systemic lupus erythematosus.

A E M van Nieuwenhuijze1, T van Lopik, R J T Smeenk, L A Aarden.   

Abstract

OBJECTIVE: To investigate the kinetics of nucleosome leakage from apoptotic cells in an in vitro system and extrapolate the results to autoimmune disease, in particular systemic lupus erythematosus.
METHODS: A sensitive nucleosome enzyme linked immunosorbent assay (ELISA) was developed, using a monoclonal antibody (mAb) against histone 3 and an mAb against nucleosomes. Nucleosome release during apoptotic cell death was studied in Jurkat cells. AnnexinV binding (early apoptosis) and propidium iodide positivity (late apoptosis) of the cells were compared with nucleosome release at different times after apoptosis induction.
RESULTS: Nucleosomes appeared in culture supernatant of Jurkat cells 24 to 48 hours after apoptosis induction, when the cells had been late apoptotic for more than 12 hours.
CONCLUSION: Nucleosomes are released from late apoptotic Jurkat cells, with a 12 hour delay from the appearance of AnnexinV binding cells. This result suggests that in vivo scavenger mechanisms have 12 hours to remove apoptotic material from the circulation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12480662      PMCID: PMC1754285          DOI: 10.1136/ard.62.1.10

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  47 in total

Review 1.  The role of nucleosomes in lupus.

Authors:  Z Amoura; S Koutouzov; J C Piette
Journal:  Curr Opin Rheumatol       Date:  2000-09       Impact factor: 5.006

2.  Defective phagocytosis in systemic lupus erythematosus.

Authors:  J L Pablos; J J Gomez-Reino
Journal:  Eur J Clin Invest       Date:  1998-10       Impact factor: 4.686

Review 3.  Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens.

Authors:  P J Utz; P Anderson
Journal:  Arthritis Rheum       Date:  1998-07

Review 4.  Recognizing death: the phagocytosis of apoptotic cells.

Authors:  N Platt; R P da Silva; S Gordon
Journal:  Trends Cell Biol       Date:  1998-09       Impact factor: 20.808

5.  Apoptotic cell clearance in systemic lupus erythematosus. II. Role of beta2-glycoprotein I.

Authors:  A A Manfredi; P Rovere; S Heltai; G Galati; G Nebbia; A Tincani; G Balestrieri; M G Sabbadini
Journal:  Arthritis Rheum       Date:  1998-02

6.  Detection of nucleosome particles in serum and plasma from patients with systemic lupus erythematosus using monoclonal antibody 4H7.

Authors:  R C Williams; C C Malone; C Meyers; P Decker; S Muller
Journal:  J Rheumatol       Date:  2001-01       Impact factor: 4.666

7.  Somatic mutation and light chain rearrangement generate autoimmunity in anti-single-stranded DNA transgenic MRL/lpr mice.

Authors:  F Brard; M Shannon; E L Prak; S Litwin; M Weigert
Journal:  J Exp Med       Date:  1999-09-06       Impact factor: 14.307

8.  Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus.

Authors:  A Bruns; S Bläss; G Hausdorf; G R Burmester; F Hiepe
Journal:  Arthritis Rheum       Date:  2000-10

9.  Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus.

Authors:  M Herrmann; R E Voll; O M Zoller; M Hagenhofer; B B Ponner; J R Kalden
Journal:  Arthritis Rheum       Date:  1998-07

10.  Complement-dependent clearance of apoptotic cells by human macrophages.

Authors:  D Mevorach; J O Mascarenhas; D Gershov; K B Elkon
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

View more
  26 in total

1.  Defective waste disposal: does it induce autoantibodies in SLE?

Authors:  Peter J Charles
Journal:  Ann Rheum Dis       Date:  2003-01       Impact factor: 19.103

2.  DNA and factor VII-activating protease protect against the cytotoxicity of histones.

Authors:  Gerben Marsman; Helen von Richthofen; Ingrid Bulder; Florea Lupu; Jan Hazelzet; Brenda M Luken; Sacha Zeerleder
Journal:  Blood Adv       Date:  2017-11-30

Review 3.  Autoimmunity versus tolerance: can dying cells tip the balance?

Authors:  Irene C B Viorritto; Nikolay P Nikolov; Richard M Siegel
Journal:  Clin Immunol       Date:  2006-10-05       Impact factor: 3.969

Review 4.  Light, including ultraviolet.

Authors:  Emanual Maverakis; Yoshinori Miyamura; Michael P Bowen; Genevieve Correa; Yoko Ono; Heidi Goodarzi
Journal:  J Autoimmun       Date:  2009-12-16       Impact factor: 7.094

5.  Induction of TRAIL- and TNF-alpha-dependent apoptosis in human monocyte-derived dendritic cells by microfilariae of Brugia malayi.

Authors:  Roshanak Tolouei Semnani; Priyanka Goel Venugopal; Lily Mahapatra; Jason A Skinner; Francoise Meylan; Daniel Chien; David W Dorward; Damien Chaussabel; Richard M Siegel; Thomas B Nutman
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

Review 6.  Interactions of high mobility group box protein 1 (HMGB1) with nucleic acids: Implications in DNA repair and immune responses.

Authors:  Pooja Mandke; Karen M Vasquez
Journal:  DNA Repair (Amst)       Date:  2019-09-16

7.  Toll-like receptor 9 enhances bacterial clearance and limits lung consolidation in murine pneumonia caused by methicillin resistant Staphylococcus aureus.

Authors:  Anne Jan van der Meer; Achmed Achouiti; Arie van der Ende; Aicha A Soussan; Sandrine Florquin; Alex de Vos; Sacha S Zeerleder; Tom van der Poll
Journal:  Mol Med       Date:  2016-06-24       Impact factor: 6.354

8.  Nucleosomes and neutrophil activation in sickle cell disease painful crisis.

Authors:  Marein Schimmel; Erfan Nur; Bart J Biemond; Gerard J van Mierlo; Shabnam Solati; Dees P Brandjes; Hans-Martin Otten; John-John Schnog; Sacha Zeerleder
Journal:  Haematologica       Date:  2013-08-02       Impact factor: 9.941

9.  Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer Therapies.

Authors:  Jill A Gallaher; Pedro M Enriquez-Navas; Kimberly A Luddy; Robert A Gatenby; Alexander R A Anderson
Journal:  Cancer Res       Date:  2018-01-30       Impact factor: 12.701

10.  Tissue factor pathway inhibitor is an inhibitor of factor VII-activating protease.

Authors:  F Stephan; I Dienava-Verdoold; I Bulder; D Wouters; A E Mast; H Te Velthuis; L A Aarden; S Zeerleder
Journal:  J Thromb Haemost       Date:  2012-06       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.